Insights

Strategic Alliance Exact Sciences is now part of Abbott, signaling a potential cross-sell of Abbott’s diagnostics and device portfolio to Exact Sciences’ cancer screening clients, with a focus on integrated solutions across diagnostics and testing services.

Cybersecurity Opportunity Repeated cybersecurity incidents and data breach lawsuits indicate a strong need for robust data protection, privacy governance, and secure data exchange solutions to protect patient records and clinical data across the combined entity.

Scale & Reach Abbott’s global footprint and large workforce combined with Exact Sciences’ cancer screening capabilities create opportunities to upsell enterprise-grade IT and healthcare tech platforms, cloud services, and global deployment of diagnostic workflows.

Data & Analytics With IBM SPSS and Oracle Cloud in the tech stack, there is potential to offer advanced analytics, predictive modeling, and AI-driven insights to optimize screening programs, patient outcomes, and operational efficiency.

Security-Driven Solutions Given the documented extortion campaigns and vishing attacks targeting the organization, there is a market need for comprehensive cybersecurity services, identity and access management, data loss prevention, and incident response offerings tailored to healthcare diagnostics.

Similar companies to Exact Sciences

Exact Sciences Tech Stack

Exact Sciences uses 8 technology products and services including iCIMS, Canva, CDK Global, and more. Explore Exact Sciences's tech stack below.

Media & News

Exact Sciences's Email Address Formats

Exact Sciences uses at least 4 email formats:
Exact Sciences Email FormatsExamplePercentage
FLast@exactsciences.comJDoe@exactsciences.com
91%
FiLast@exactsciences.comJoDoe@exactsciences.com
5%
First_Last@exactsciences.comJohn_Doe@exactsciences.com
2%
First.Last@exactsciences.comJohn.Doe@exactsciences.com
2%

Frequently Asked Questions

What is Exact Sciences's phone number?

Minus sign iconPlus sign icon
You can contact Exact Sciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Exact Sciences's stock symbol?

Minus sign iconPlus sign icon
Exact Sciences is a publicly traded company; the company's stock symbol is EXAS.

What is Exact Sciences's official website and social media links?

Minus sign iconPlus sign icon
Exact Sciences's official website is exactsciences.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Exact Sciences generate?

Minus sign iconPlus sign icon
As of August 2026, Exact Sciences's annual revenue is estimated to be $1B - $10B.

What is Exact Sciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Exact Sciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exact Sciences have currently?

Minus sign iconPlus sign icon
As of August 2026, Exact Sciences has approximately 5.1K employees across 5 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: G. N. B., Chief Executive Officer: J. T. and Chief Medical Officer, International: S. B. Explore Exact Sciences's employee directory with LeadIQ.

What industry does Exact Sciences belong to?

Minus sign iconPlus sign icon
Exact Sciences operates in the Biotechnology Research industry.

What technology does Exact Sciences use?

Minus sign iconPlus sign icon
Exact Sciences's tech stack includes iCIMS, Canva, CDK Global, Oracle Cloud, Microsoft SQL Server, Google Workspace, IBM SPSS and DocuSign.

What is Exact Sciences's email format?

Minus sign iconPlus sign icon
Exact Sciences's email format typically follows the pattern of FLast@exactsciences.com. Find more Exact Sciences email formats with LeadIQ.

How much funding has Exact Sciences raised to date?

Minus sign iconPlus sign icon
As of August 2026, Exact Sciences has raised $2.8B in funding. The last funding round occurred on Apr 11, 2024 for $621M.
Exact Sciences logo

Exact Sciences

Biotechnology ResearchWisconsin, United States5001-10000 Employees

Exact Sciences is a biotechnology research company based in Madison, Wisconsin, United States. The company employs between 5,001 and 10,000 people. It develops cancer diagnostics and is known for its colorectal cancer screening test, Cologuard, and has partnered with Walgreens to promote non-invasive screening options and integrate screening programs into pharmacy operations. In 2026, Exact Sciences relocated its U.S. offices from Massachusetts to Madison and later integrated with Abbott, a global healthcare company. The company is pursuing a pipeline of cancer diagnostics, including Oncodetect, a minimal residual disease test for early-stage triple-negative breast cancer.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
EXAS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
5001-10000

Section iconFunding & Financials

  • $2.8B

    Exact Sciences has raised a total of $2.8B of funding over 6 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $621M as a Post IPO Debt.

  • $1B - $10B

    Exact Sciences's revenue is estimated to be in the range of $1B - $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.